Flora Fertility Secures $5M Seed for US Fertility Insurance Push

Flora Fertility, a Calgary and Chicago-based company, closed a $5 million seed funding round to support the nationwide rollout of its individually owned fertility insurance product in the US starting 2026. The investment will enable scaling of the portable insurance platform, which allows personal ownership of fertility coverage, addressing gaps in traditional employer-tied benefits. Previously, the startup secured $1.5 million in pre-seed funding in 2024 to build its foundation in the fertility sector .

ManchesterStory, an Iowa-based InsurTech investor, led the round, joined by Slauson & Co., TruStage Ventures, BDC Capital, Marathon Fund, Adara Venture Capital, and prior backers . This capital injection positions Flora to expand operations amid rising demand for accessible fertility solutions, particularly as fertility treatments grow more common yet remain financially burdensome for many. The firm's model emphasizes portability, enabling coverage to follow individuals regardless of job changes, a key differentiator in the insurtech space .

In the broader healthcare landscape, Flora's progress highlights investor focus on women's health and fertility innovations, where coverage remains inconsistent across regions. The US launch targets a market needing flexible insurance amid evolving family planning trends, while Canada plans signal cross-border ambitions. This funding builds momentum for Flora to capture share in a niche blending insurtech with reproductive health services .